144 related articles for article (PubMed ID: 19008912)
1. Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells.
Isshiki K; He Z; Maeno Y; Ma RC; Yasuda Y; Kuroki T; White GS; Patti ME; Weir GC; King GL
Kidney Int; 2008 Dec; 74(11):1434-43. PubMed ID: 19008912
[TBL] [Abstract][Full Text] [Related]
2. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.
Kong YL; Shen Y; Ni J; Shao DC; Miao NJ; Xu JL; Zhou L; Xue H; Zhang W; Wang XX; Lu LM
Acta Pharmacol Sin; 2016 Feb; 37(2):217-27. PubMed ID: 26775660
[TBL] [Abstract][Full Text] [Related]
3. The somatotropic axis during the physiological estrus cycle in dairy heifers--Effect on hepatic expression of GHR and SOCS2.
Mense K; Meyerholz M; Gil Araujo M; Lietzau M; Knaack H; Wrenzycki C; Hoedemaker M; Piechotta M
J Dairy Sci; 2015 Apr; 98(4):2409-18. PubMed ID: 25704974
[TBL] [Abstract][Full Text] [Related]
4. SOCS2 exacerbates myocardial injury induced by ischemia/reperfusion in diabetic mice and H9c2 cells through inhibiting the JAK-STAT-IGF-1 pathway.
Sheng M; Huang Z; Pan L; Yu M; Yi C; Teng L; He L; Gu C; Xu C; Li J
Life Sci; 2017 Nov; 188():101-109. PubMed ID: 28867579
[TBL] [Abstract][Full Text] [Related]
5. Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription.
Chen Y; Lin G; Huo JS; Barney D; Wang Z; Livshiz T; States DJ; Qin ZS; Schwartz J
Endocrinology; 2009 Aug; 150(8):3645-54. PubMed ID: 19406940
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy.
Zhou Y; Lv C; Wu C; Chen F; Shao Y; Wang Q
Acta Histochem; 2014 Jun; 116(5):981-8. PubMed ID: 24802166
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1.
Mulligan C; Rochford J; Denyer G; Stephens R; Yeo G; Freeman T; Siddle K; O'Rahilly S
J Biol Chem; 2002 Nov; 277(45):42480-7. PubMed ID: 12213819
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
9. Favorable prognostic value of SOCS2 and IGF-I in breast cancer.
Haffner MC; Petridou B; Peyrat JP; Révillion F; Müller-Holzner E; Daxenbichler G; Marth C; Doppler W
BMC Cancer; 2007 Jul; 7():136. PubMed ID: 17651480
[TBL] [Abstract][Full Text] [Related]
10. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
[TBL] [Abstract][Full Text] [Related]
13. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of STAT3 activation by insulin-like growth factor I receptor.
Zong CS; Chan J; Levy DE; Horvath C; Sadowski HB; Wang LH
J Biol Chem; 2000 May; 275(20):15099-105. PubMed ID: 10747872
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CASC2 Alleviates the Progression of Diabetic Nephropathy by Regulating the miR-144/SOCS2 Signalling Axis.
Min XQ; Xie Y
Kidney Blood Press Res; 2020; 45(6):837-849. PubMed ID: 33227790
[TBL] [Abstract][Full Text] [Related]
16. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.
Pugliese G; Pricci F; Locuratolo N; Romeo G; Romano G; Giannini S; Cresci B; Galli G; Rotella CM; Di Mario U
Diabetologia; 1996 Jul; 39(7):775-84. PubMed ID: 8817101
[TBL] [Abstract][Full Text] [Related]
17. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
18. IgA Enhances IGF-1 Mitogenic Activity Via Receptor Modulation in Glomerular Mesangial Cells: Implications for IgA-Induced Nephropathy.
Al-Eisa A; Dhaunsi GS
Kidney Blood Press Res; 2017; 42(3):391-397. PubMed ID: 28668953
[TBL] [Abstract][Full Text] [Related]
19. Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.
Dobie R; Ahmed SF; Staines KA; Pass C; Jasim S; MacRae VE; Farquharson C
J Cell Physiol; 2015 Nov; 230(11):2796-806. PubMed ID: 25833299
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
Singh LP; Jiang Y; Cheng DW
Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
